Electrocardiographic markers of atrial cardiopathy (AC) have been previously associated with stroke outcomes. Whether the prognostic significance of AC for stroke mortality varies by baseline blood pressure (BP) severity has not been established. The authors used data from the Third National Health and Nutrition Examination Survey (NHANES III) to evaluate whether BP category modifies the association between ECG-defined AC and subsequent stroke death.
Study population and data source
The analysis included 7,191 adults from NHANES III who were free of known cardiovascular disease and who had baseline 12‑lead ECG recordings. NHANES III is a nationally representative survey; the investigators used the publicly available, de-identified dataset approved by the National Center for Health Statistics (NCHS) Institutional Review Board.
Definition of atrial cardiopathy
AC was defined by three ECG markers available in the dataset: prolonged P-wave duration (≥120 ms), abnormal P-wave axis (less than 0° or greater than 75°), and deep terminal negativity of the P wave in V1 (≤ -100 µV). Analyses considered both AC presence (one marker versus none) and AC burden (risk increment per additional AC marker).
Blood pressure stratification
Participants were stratified by baseline BP into three groups: normal/elevated (<130/80 mmHg), stage 1–2 hypertension (130–159/80–99 mmHg), and severe hypertension (≥160/100 mmHg). The investigators assessed whether BP category modified the association between AC metrics and stroke mortality.
Outcome and statistical analysis
The primary outcome was stroke mortality during follow-up. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for stroke death associated with AC burden and AC presence, with multivariable adjustment for covariates (the specific adjusted covariates are reported in the source). Interaction between AC measures and BP category was formally tested.
Follow-up and events
Participants were followed for a median of 13.8 years, during which 183 stroke deaths occurred.
Primary associations
In multivariable-adjusted models, AC burden was associated with higher stroke mortality: each additional AC marker was associated with a 41% increase in risk (HR 1.41; 95% CI 1.13–1.77).
Interaction with blood pressure
The association between AC burden and stroke mortality was significantly modified by baseline BP category (interaction P = 0.003). When stratified by BP, the HRs per additional AC marker were:
These results indicate a progressively stronger association between AC burden and stroke death with greater BP severity. A similar pattern was noted for AC presence (one marker vs none), although the interaction between AC presence and BP category did not reach statistical significance according to the source.
In this NHANES III cohort of adults without known cardiovascular disease, ECG-defined atrial cardiopathy burden was independently associated with increased stroke mortality, and this association was substantially stronger among individuals with severe hypertension. These findings support the concept that blood pressure severity modifies the prognostic significance of AC for stroke death.
Preprint status
This report is a preprint and has not been peer reviewed. The authors note this status; the findings should not be used to change clinical practice without confirmation.
Scope of data and measurement
Analyses used a single baseline ECG and a single BP assessment from NHANES III. The ECG markers used to define AC are standard but limited to the three specified measurements; other markers or imaging-based definitions of atrial disease were not reported in this source. The source did not provide details here on additional sensitivity analyses, residual confounding, or treatment changes during follow-up.
Implications
The observed interaction suggests clinicians and researchers should consider BP severity when interpreting ECG markers of atrial disease as risk indicators for stroke mortality. The findings may inform risk stratification and motivate further studies to determine whether BP control modifies risk associated with atrial cardiopathy.
The analysis used publicly available NHANES III data from the National Center for Health Statistics (NCHS). The original survey protocol was approved by the NCHS Institutional Review Board, and written informed consent was obtained from participants. The study used de-identified data and followed applicable ethical guidelines as reported by the authors.
The authors reported one competing interest: Brian C. Boursiquot has consulted for Ambience Healthcare. The remaining authors declared no relevant financial or non-financial interests. The source reiterates that the report is a preprint and has not been certified by peer review.